Leerink Partnrs boosted their FY2024 EPS estimates for shares of Beigene in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now ...

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced a collaboration with BeiGene Ltd., a global oncology company that intends to change its name to ...

Locally based brokerage firm STRIVE has arranged the sale of  Village at Broad II, a 17,112-square-foot retail strip center in Mansfield, a southern suburb of Fort Worth. The center was fully leased ...

BeiGene, a global biotech firm that develops cancer medicines, has opened a 400,000-square-foot life sciences facility in ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BeiGene (ONC – Research Report) and Embecta ...